Please assess the completion status of the following clinical trial:

Trial Title: Endoscopic Abraxane Injection Into Pancreatic Cysts

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Mucinous cysts (premalignant or malignant cysts of the pancreas)~* Normal organ and marrow function~* Baseline CT within 6 months of enrollment~Exclusion Criteria:~* Pregnant or breastfeeding~* Acute active pancreatitis~* Complicated pancreatic cysts~* Subjects who do not speak English

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Albumin bound paclitaxel (Type: EXPERIMENTAL): Albumin bound paclitaxel will be administered into the mucinous cyst of pancreas in endoscopy procedure.

Based on this trial design, predict the completion outcome and termination type (if applicable).